CYPRALIS LTD has a total of 23 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in United Kingdom, United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SHAPIRO LELAND, ONYX THERAPEUTICS INC and ADAIR CHARLES DAVID.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | United States | 5 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Australia | 1 | |
#7 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Fliri Hans Georg | 8 |
#2 | Ford Rhonan Lee | 8 |
#3 | Vong Antonio Kuok Keong | 8 |
#4 | Peel Michael | 6 |
#5 | Zeng Li | 4 |
#6 | Yu Shengqiang | 4 |
#7 | Scribner Andrew | 2 |
#8 | Watashi Koichi | 2 |
#9 | Shimura Satomi | 2 |
#10 | Highton Adrian John | 1 |
Publication | Filing date | Title |
---|---|---|
GB202010050D0 | Macrocyclic compounds and uses thereof | |
GB202005476D0 | Cyclosporin analogues and uses thereof | |
GB201908967D0 | Macrocyclic compounds and uses thereof | |
GB201810121D0 | Macrocyclic compounds and uses thereof | |
GB201718351D0 | Depsipeptide analogue and use thereof | |
GB201711749D0 | Cyclosporin analogues and uses thereof | |
CN108025039A | Novel macrocyclic compound | |
GB201401792D0 | Beta-lactam compounds | |
AU2013326231A1 | Cyclic depsipeptide compounds and their uses |